Literature DB >> 7649556

Haplotype analysis of common transthyretin mutations.

M R Almeida1, N Aoyama-Oishi, Y Sakaki, G Holmgren, D Ulf, A Ferlini, F Salvi, M Munar-Oués, M D Benson, M Skinner.   

Abstract

The most frequent transthyretin (TTR) variant associated with hereditary amyloidosis is TTR Met 30, which has its major focus in Portugal, although it also occurs in many other countries. The distribution of the mutation and its occurrence in a CpG dinucleotide lead us to question the origin of the mutation and the possibility of its having originated in Portugal. In order to investigate these questions, we studied the distribution of haplotypes associated with the Met 30 mutation in families from different European countries. All the analysed Portuguese families presented the same haplotype associated with the Met 30 mutation (haplotype I). The same was found for the Swedish and Spanish families studied. However, a distinct haplotype (haplotype III) was found in three families, one Italian, one English and one Turkish. These results suggest that, although the Portuguese Met 30 carriers might have one founder, the mutation probably recurred in populations in Europe in a similar manner to that reported in Japan. In this study, we have also analysed the haplotypes associated with other TTR variants frequent in the Portuguese population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649556     DOI: 10.1007/BF00210422

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden.

Authors:  R Andersson
Journal:  Acta Med Scand Suppl       Date:  1976

2.  Molecular analyses of an acidic transthyretin Asn 90 variant.

Authors:  M J Saraiva; M R Almeida; I L Alves; P Moreira; M Gawinowicz; P P Costa; S Rauh; A Banhzoff; K Altland
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

3.  Discrimination of peripheral polyneuropathies caused by TTR variant or diabetes in the same pedigree through protein studies.

Authors:  A Ferlini; G Romeo; C A Tassinari; M J Saraiva; P P Costa; F Salvi
Journal:  Adv Neurol       Date:  1988

4.  Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis.

Authors:  G Holmgren; E Holmberg; A Lindström; E Lindström; I Nordenson; O Sandgren; L Steen; B Svensson; E Lundgren; A von Gabain
Journal:  Clin Genet       Date:  1988-03       Impact factor: 4.438

5.  Structure of the mutant prealbumin gene responsible for familial amyloidotic polyneuropathy.

Authors:  K Yoshioka; H Sasaki; N Yoshioka; H Furuya; T Harada; S Kito; Y Sakaki
Journal:  Mol Biol Med       Date:  1986-08

6.  Presence of a plasma transthyretin (prealbumin) variant in familial amyloidotic polyneuropathy in a kindred of Greek origin.

Authors:  M J Saraiva; W Sherman; D S Goodman
Journal:  J Lab Clin Med       Date:  1986-07

7.  The high frequency of TTR M30 in familial amyloidotic polyneuropathy is not due to a founder effect.

Authors:  S Ii; S S Sommer
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

8.  Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type).

Authors:  S Tawara; M Nakazato; K Kangawa; H Matsuo; S Araki
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

9.  Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis.

Authors:  H H Harrison; E D Gordon; W C Nichols; M D Benson
Journal:  Am J Med Genet       Date:  1991-06-15

10.  Transthyretin Ser 6 gene frequency in individuals without amyloidosis.

Authors:  D R Jacobson; I L Alves; M J Saraiva; S N Thibodeau; J N Buxbaum
Journal:  Hum Genet       Date:  1995-03       Impact factor: 4.132

View more
  3 in total

1.  A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.

Authors:  Miguel Alves-Ferreira; Teresa Coelho; Diana Santos; Jorge Sequeiros; Isabel Alonso; Alda Sousa; Carolina Lemos
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

2.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.

Authors:  K Yamamoto; S Ikeda; N Hanyu; S Takeda; N Yanagisawa
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

3.  Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.

Authors:  Thomas Rudolph; Martin Wilhelm Kurz; Elisabeth Farbu
Journal:  Clin Med Res       Date:  2008-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.